NewAmsterdam Pharma Company N.V. (NAMS) Revenue 2022–2025
NewAmsterdam Pharma Company N.V. (NAMS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$22.5MFY2025 · since FY2022: $102.7M → $22.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $22.5M | -50.6% |
| FY2024 | $45.6M | +223.4% |
| FY2023 | $14.1M | -86.3% |
| FY2022 | $102.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice